Are Fidelity Index Funds Going to Be OK?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Fidelity's former ceo, ned johnson, once expressed scepticism over whether index funds would ever take off. The passive investment business she re vamped, has become one of the biggest money managers in the world. So what does that then mean for companies? Hannah cushler is the f ts global pharmocutical correspondent.

Dozens of biotech companies are running low on cash and face an uphill struggle to raise fresh funds, Fidelity’s little-known passive investment business Geode Capital Management surged to $1tn in assets last year. Plus, the FT’s US business editor, Andrew Edgecliffe-Johnson, explains why Peloton’s latest turmoil makes it an attractive acquisition target.

Mentioned in this podcast:

Bursting ‘Biotech bubble’ inflicts pain on tourist investors and innovators

Fidelity’s index fund business Geode hits $1tn in assets

Turmoil at Peloton makes it opportunistic target for Nike and Amazon

Chipotle: burrito index reflects inflationary guac attack

The FT News Briefing is produced by Fiona Symon and Marc Filippino. The show’s editor is Jess Smith. Additional help by Peter Barber and Gavin Kallmann. The show’s theme song is by Metaphor Music. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.